Proper application of the value of a statistical life (VSL) is essential to preventing the systematic undervaluation of life throughout the world. The values used by U.S. federal agencies to monetize prospective risk reductions formerly were too low but have increased over time and are now in a range consistent with the economic literature. However, the values agencies assign to fatalities in setting regulatory sanctions are extremely low—often a fraction of the current estimates for VSL estimates used in regulatory contexts. Further, other countries still monetize risk reductions using techniques that undervalue life relative to VSL estimates.
The origin of monetizing mortality risks in the United States and other countries can be traced to application of the human capital approach, which some agencies termed the “cost of death.” In the view of agency officials, life was too sacred to value, so instead they assigned a monetary value to the deaths. When I introduced the VSL in 1982 to resolve the dispute between the Occupational Safety and Health Administration (OSHA) and the Office of Management and Budget over the proposed hazard communication standard, the shift to the VSL as the measure of mortality benefits boosted benefits by a factor of 10. The bolstering of benefit assessments through the use of the VSL reflects the historical role of the VSL in providing an economic efficiency rationale for benefit assessments, making regulations more stringent than if set based on cost-of-death values.
